BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33224312)

  • 1. miR-106a-5p Functions as a Tumor Suppressor by Targeting VEGFA in Renal Cell Carcinoma.
    Ma J; Wang W; Azhati B; Wang Y; Tusong H
    Dis Markers; 2020; 2020():8837941. PubMed ID: 33224312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
    Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
    Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
    Pan YJ; Wei LL; Wu XJ; Huo FC; Mou J; Pei DS
    Cell Death Dis; 2017 Oct; 8(10):e3155. PubMed ID: 29072688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
    Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
    Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK.
    Zhi F; Zhou G; Shao N; Xia X; Shi Y; Wang Q; Zhang Y; Wang R; Xue L; Wang S; Wu S; Peng Y; Yang Y
    PLoS One; 2013; 8(8):e72390. PubMed ID: 24013584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
    Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
    Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer.
    Zhang C; Pan X; Peng X; Liu K; Wang J; Zhao L; Chen X; Huang G; Li H; Ye J; Lai Y
    J Clin Lab Anal; 2021 Feb; 35(2):e23599. PubMed ID: 33247622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B
    J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
    Li H; Pan X; Gui Y; Quan J; Li Z; Zhao L; Guan X; Xu J; Xu W; Lai Y
    Cancer Biomark; 2019; 24(2):153-158. PubMed ID: 30689558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.